Coronavirus update: outbreak has not disrupted drug supplies, vaccine development advancing

The 2019-nCoV outbreak has not adversely affected supplies of drugs or active pharmaceutical ingredients to the U.S., FDA Commissioner Stephen Hahn said Friday. “At this moment we have received no reports from manufacturers of disruptions to the pharmaceutical supply chain,” he said at a briefing by the Coronavirus Task Force.

Risks to the U.S. supply chain, public health measures, and the development of therapies and vaccines will be discussed at a Senate Homeland Security Committee roundtable on Feb. 12. Expected participants include Robert Kadlec, assistant secretary for preparedness and response (ASPR) at HHS; former FDA Commissioner Scott Gottlieb; and Luciana Borio, VP at IN-Q-Tel, a non-profit investment firm and former director for medical and biodefense preparedness at the White House National Security Council...